JPS62201884A
(ja)
*
|
1986-02-28 |
1987-09-05 |
Tokyo Tanabe Co Ltd |
ベンズイミダゾール誘導体及びその製造法
|
JPH0768125B2
(ja)
*
|
1988-05-18 |
1995-07-26 |
エーザイ株式会社 |
酸不安定化合物の内服用製剤
|
AT391693B
(de)
*
|
1988-11-15 |
1990-11-12 |
Cl Pharma |
Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
|
US5294629A
(en)
*
|
1988-11-22 |
1994-03-15 |
Meiji Seika Kaisha, Ltd. |
Benzothiazole and benzimidazole derivatives and antiulcer agent containing the same
|
EG19302A
(en)
*
|
1988-12-22 |
1994-11-30 |
Haessle Ab |
Compound with gastric acid inhibitory effect and process for its preparation
|
SE8804629D0
(sv)
*
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New therapeutically active compounds
|
US4965269A
(en)
*
|
1989-12-20 |
1990-10-23 |
Ab Hassle |
Therapeutically active chloro substituted benzimidazoles
|
US5049674A
(en)
*
|
1989-12-20 |
1991-09-17 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
ES2024357A6
(es)
*
|
1990-12-05 |
1992-02-16 |
Genesis Para La Investigacion |
Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina.
|
NZ244301A
(en)
*
|
1991-09-20 |
1994-08-26 |
Merck & Co Inc |
Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
|
US5504082A
(en)
*
|
1992-06-01 |
1996-04-02 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Pyridine compound and pharmaceutical compostions
|
EP0585722B1
(fr)
*
|
1992-08-21 |
1996-05-15 |
Eisai Co., Ltd. |
Dérivés de benzimidasoles comme agent antibiotique contre le campylobacter pylÔne
|
JPH08507054A
(ja)
*
|
1993-02-17 |
1996-07-30 |
ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
ヘリコバクターバクテリアに対抗するための置換されたヘテロアリールアルキルチオピリジン
|
UA32583C2
(uk)
*
|
1993-06-29 |
2001-02-15 |
Бік Гульден Ломберг Хеміше Фабрік Гмбх |
Похідні арилтіоалкілтіопіридину
|
TW280770B
(fr)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
KR960705811A
(ko)
*
|
1993-10-29 |
1996-11-08 |
고오야 다다시 |
피리딘 화합물 및 그의 약학적 용도[pyridine compound and medicinal use thereof]
|
KR0142815B1
(ko)
*
|
1994-12-02 |
1998-07-15 |
정도언 |
신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체
|
KR0179401B1
(ko)
*
|
1994-02-28 |
1999-03-20 |
송택선 |
신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체
|
HRP960232A2
(en)
*
|
1995-07-03 |
1998-02-28 |
Astra Ab |
A process for the optical purification of compounds
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
KR970032861A
(ko)
*
|
1995-12-29 |
1997-07-22 |
김준웅 |
헬리코박터 피로리 제거용 약제 투여방법
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
EP0983263A1
(fr)
*
|
1997-05-30 |
2000-03-08 |
Dr. Reddy's Research Foundation |
Nouveaux benzimidazoles utilises comme agents antiulcereux, leur procede de preparation et compositions pharmaceutiques les contenant
|
WO1999004816A1
(fr)
|
1997-07-25 |
1999-02-04 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Inhibiteur de la pompe a protons en combinaison therapeutique avec des substances antibacteriennes
|
US7230014B1
(en)
|
1997-10-14 |
2007-06-12 |
Eisai Co., Ltd. |
Pharmaceutical formulation comprising glycine as a stabilizer
|
AU1361399A
(en)
*
|
1997-10-14 |
1999-05-03 |
Eisai Co. Ltd. |
Pharmaceutical formulation comprising glycine as a stabilizer
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
WO1999036422A1
(fr)
|
1998-01-14 |
1999-07-22 |
The Uab Research Foundation |
Procede de synthese et de criblage d'inhibiteurs d'enzyme synthetase nad bacterienne, composes a base de cette enzyme et procedes de traitement des infections bacteriennes et microbiennes au moyen d'inhibiteurs de ladite enzyme
|
DE19815634A1
(de)
*
|
1998-04-07 |
1999-10-14 |
Bayer Ag |
Verfahren zur Herstellung von 3-Methoxy-1-propanol
|
EP1073333A4
(fr)
*
|
1998-04-30 |
2005-06-15 |
Sepracor Inc |
Compositions a base de s-rabeprazole et procedes
|
WO1999055157A1
(fr)
*
|
1998-04-30 |
1999-11-04 |
Sepracor Inc. |
Compositions a base de r-rabeprazole et procedes
|
WO2000000474A1
(fr)
*
|
1998-06-26 |
2000-01-06 |
Russinsky Limited |
Blocs constitutifs de pyrimidine utilises comme intermediaires dans la synthese de composes pharmaceutiquement actifs
|
YU10101A
(sh)
|
1998-08-10 |
2003-10-31 |
Partnership Of Michael E. Garst George Sachs And Jai Moo Shin |
Prolekovi inhibitori proton pumpe
|
US6093734A
(en)
*
|
1998-08-10 |
2000-07-25 |
Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin |
Prodrugs of proton pump inhibitors
|
PT1105105E
(pt)
|
1998-08-12 |
2006-07-31 |
Altana Pharma Ag |
Forma de administracao oral para piridin-2-ilmetilsulfinil-1h-benzimidazois
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
JP3926936B2
(ja)
*
|
1998-11-16 |
2007-06-06 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スルホキシド誘導体・アセトン錯体およびその製造法
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
US6362202B1
(en)
|
1999-03-02 |
2002-03-26 |
Sepracor Inc. |
Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
|
US6353005B1
(en)
|
1999-03-02 |
2002-03-05 |
Sepracor, Inc. |
Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
|
US6174902B1
(en)
|
1999-04-28 |
2001-01-16 |
Sepracor Inc. |
R-rabeprazole compositions and methods
|
DE60021570T2
(de)
|
1999-06-07 |
2006-05-24 |
Altana Pharma Ag |
Neue zubereitung und darreichungsform enthaltend einen säurelabilen protonenpumpeninhibitor
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
WO2001074810A2
(fr)
*
|
2000-03-31 |
2001-10-11 |
Ortho Mcneil Pharmaceutical, Inc. |
Procede d'utilisation de 2-aryloxyalkylaminobenzoxazoles et de 2-aryloxyalkylaminobenzothiazoles comme antagonistes vis-a-vis du recepteur h3
|
EP1359912A4
(fr)
*
|
2000-06-19 |
2006-05-03 |
Eisai Co Ltd |
Nouvelles methodes utilisant des derives de pyridine
|
US6544556B1
(en)
*
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
WO2002026210A2
(fr)
*
|
2000-09-29 |
2002-04-04 |
Geneva Pharmaceuticals Inc. |
Formulation d'inhibiteur de la pompe à protons
|
DK1341528T3
(da)
|
2000-12-07 |
2012-03-26 |
Nycomed Gmbh |
Hurtigtopløsende tablet omfattende en syrelabil aktiv bestanddel
|
US7988999B2
(en)
|
2000-12-07 |
2011-08-02 |
Nycomed Gmbh |
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
|
BR0115989A
(pt)
|
2000-12-07 |
2004-01-13 |
Altana Pharma Ag |
Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido
|
NL1018295C2
(nl)
*
|
2001-06-15 |
2002-12-17 |
Dsm Nv |
Werkwijze voor de bereiding van 4-chloor-pyridine-n-oxiden.
|
CN1243749C
(zh)
*
|
2001-09-18 |
2006-03-01 |
泽里新药工业株式会社 |
苯并咪唑衍生物
|
AU2002365936A1
(en)
*
|
2001-11-16 |
2003-09-02 |
Eisai Co. Ltd |
Compositions and methods to treat gastrointestinal disorders
|
SE0104295D0
(sv)
*
|
2001-12-18 |
2001-12-18 |
Astrazeneca Ab |
New process
|
EP1487820A1
(fr)
*
|
2002-03-26 |
2004-12-22 |
Dr. Reddy's Laboratories Ltd. |
Formes cristallines de rabeprazole sodique
|
AU2003241464A1
(en)
*
|
2002-05-17 |
2003-12-02 |
Eisai Co., Ltd. |
Compositions and methods using proton pump inhibitors
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
AU2003254282A1
(en)
*
|
2002-08-01 |
2004-02-23 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
AT413538B
(de)
*
|
2002-10-01 |
2006-03-15 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur herstellung von substituierten pyridin-n-oxid-verbindungen
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
PL375818A1
(en)
|
2002-12-06 |
2005-12-12 |
Altana Pharma Ag |
Process for preparing optically pure active compounds
|
CA2507889C
(fr)
|
2002-12-06 |
2012-02-07 |
Altana Pharma Ag |
Procede de preparation de (s)-pantoprazole
|
AR046245A1
(es)
*
|
2002-12-16 |
2005-11-30 |
Ranbaxy Lab Ltd |
Sales de calcio de rabeprazol
|
CA2510849A1
(fr)
*
|
2002-12-19 |
2004-07-08 |
Teva Pharmaceutical Industries Ltd |
Etats solides de sodium de pantoprazole, leurs procedes de preparation et procedes de preparation d'hydrates de sodium de pantoprazole connus
|
EP1583507A2
(fr)
*
|
2003-01-07 |
2005-10-12 |
Ranbaxy Laboratories Limited |
Sels de magnesium de derives de l'imidazole
|
US20040180935A1
(en)
*
|
2003-02-28 |
2004-09-16 |
Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Inc. |
Crystalline form Z of rabeprazole sodium and process for preparation thereof
|
EP1601667A2
(fr)
*
|
2003-03-12 |
2005-12-07 |
Teva Pharmaceutical Industries Limited |
Formes solides cristallines et amorphes de pantoprazole et procedes de preparation de ces formes
|
JP4355703B2
(ja)
*
|
2003-03-13 |
2009-11-04 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
歯ぎしりの予防剤または治療剤
|
EP1607395B1
(fr)
*
|
2003-03-24 |
2011-05-04 |
Eisai R&D Management Co., Ltd. |
Procédé de préparation de sel de sodium de rabeprazole amorphe
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
US7524837B2
(en)
*
|
2003-05-12 |
2009-04-28 |
Janssen Pharmaceutica N.V. |
Benzotriazapinone salts and methods for using same
|
EP1615913A2
(fr)
*
|
2003-06-10 |
2006-01-18 |
Teva Pharmaceutical Industries Limited |
Procede de preparation de benzimidazoles 2- (pyridinyl)methyl]sulfinyle substitues et nouveau derives chlorures de pantoprazole
|
CA2529984C
(fr)
*
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
|
WO2005016917A1
(fr)
*
|
2003-07-15 |
2005-02-24 |
Allergan, Inc. |
Procede de preparation de promedicaments isomeriquement purs d'inhibiteurs de la pompe a protons
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
JP2007504261A
(ja)
*
|
2003-09-03 |
2007-03-01 |
エイジーアイ・セラピューティクス・リサーチ・リミテッド |
プロトンポンプ阻害剤製剤、並びに当該製剤を製造及び使用する方法関連出願の表示
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
WO2005039640A1
(fr)
*
|
2003-10-03 |
2005-05-06 |
Allergan Inc. |
Compositions contenant des peptides en trefle et/ou des mucoadhesifs et des promedicaments d'un inhibiteur de pompe a proton
|
EP1716136A1
(fr)
|
2004-02-11 |
2006-11-02 |
Ulkar Kimya Sanayii Ve Ticaret A.S. |
Pyridine benzimidazole sulphoxides de grande pureté
|
US20070161679A1
(en)
*
|
2004-02-18 |
2007-07-12 |
Allergan, Inc. |
Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
|
AU2005216862A1
(en)
*
|
2004-02-18 |
2005-09-09 |
Allergan, Inc. |
Compositions comprising prodrugs of proton pump inhibitors
|
CA2561700A1
(fr)
*
|
2004-04-16 |
2005-12-15 |
Santarus, Inc. |
Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique
|
JP2007536349A
(ja)
*
|
2004-05-07 |
2007-12-13 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規の医薬剤形及び製造方法
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
JP4884967B2
(ja)
*
|
2004-06-30 |
2012-02-29 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ベンズイミダゾール誘導体塩沈殿物の製造方法
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060024362A1
(en)
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
WO2006013960A1
(fr)
*
|
2004-08-06 |
2006-02-09 |
Eisai R & D Management Co., Ltd. |
Sels de derive de benzimidazole avec des amines et procede de production de ceux-ci
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
WO2006024890A1
(fr)
*
|
2004-08-30 |
2006-03-09 |
Apollo International Limited |
Procede ameliore de preparation de rabeprazole sodique sous forme amorphe
|
WO2006034632A1
(fr)
*
|
2004-09-30 |
2006-04-06 |
Jiangsu Hansen Pharmaceutical Co., Ltd. |
Nouveau compose prazole et son utilisation
|
CN100364989C
(zh)
*
|
2004-09-30 |
2008-01-30 |
江苏豪森药业股份有限公司 |
拉唑类衍生物及其盐和用途
|
EP2417986A1
(fr)
|
2004-11-22 |
2012-02-15 |
Anadis Ltd. |
Compositions bioactives
|
NZ561008A
(en)
*
|
2005-02-21 |
2009-09-25 |
Cipla Ltd |
New process for synthesis of proton pump inhibitors, namely Rabeprazole sodium
|
WO2006120701A1
(fr)
*
|
2005-03-30 |
2006-11-16 |
Lupin Limited |
Procede perfectionne de fabrication de rabeprazole sodium
|
US7601737B2
(en)
|
2005-07-26 |
2009-10-13 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
GB0525710D0
(en)
*
|
2005-12-17 |
2006-01-25 |
Pliva Hrvatska D O O |
An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
EP1818331A1
(fr)
|
2006-02-14 |
2007-08-15 |
EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. |
Procédé pour la préparation de 2-[{4-(3-méthoxypropoxy)-3-méthyl-2-pyridinyl}méthylsulfinyl]-1H-benzimidazole essentiellement exempte d'impurité sulfone
|
SI2003130T1
(sl)
*
|
2006-03-10 |
2012-02-29 |
Arigen Pharmaceuticals Inc |
Nov piridinski derivat, ki ima aktivnost proti Helicobacter pylori
|
EP2007360B1
(fr)
|
2006-04-03 |
2014-11-26 |
Isa Odidi |
Dispositif d'administration à libération commandée comprenant un enrobage organosol
|
KR100771655B1
(ko)
*
|
2006-04-24 |
2007-10-30 |
주식회사 카이로제닉스 |
라베프라졸 및 그 중간체의 제조방법
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US7786309B2
(en)
|
2006-06-09 |
2010-08-31 |
Apotex Pharmachem Inc. |
Process for the preparation of esomeprazole and salts thereof
|
US7863330B2
(en)
|
2006-06-14 |
2011-01-04 |
Rottapharm S.P.A. |
Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
|
WO2008017020A2
(fr)
*
|
2006-08-03 |
2008-02-07 |
Dr. Reddy's Laboratories Limited |
Procédé de preparation d'inhibiteurs de la pompe à protons
|
US20100317689A1
(en)
*
|
2006-09-19 |
2010-12-16 |
Garst Michael E |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
CA2665226C
(fr)
|
2006-10-05 |
2014-05-13 |
Santarus, Inc. |
Nouvelles formulations pour une liberation immediate d'inhibiteurs de pompe a protons et procedes d'utilisation de ces formulations
|
WO2008047681A1
(fr)
*
|
2006-10-13 |
2008-04-24 |
Eisai R & D Management Co., Ltd. |
Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique
|
CA2667682A1
(fr)
|
2006-10-27 |
2008-05-15 |
The Curators Of The University Of Missouri |
Compositions comprenant des agents d'inhibition de la pompe a protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procedes d'utilisation
|
SI2103608T1
(sl)
|
2006-12-18 |
2012-12-31 |
Arigen Pharmaceuticals, Inc. |
Sredstvo za eradikacijo Helicobacterja pylori z inhibitorno aktivnostjo za izločanje želoldčne kisline
|
ITMI20062449A1
(it)
|
2006-12-19 |
2008-06-20 |
Dipharma Spa |
Forma cristallina di rabeprazolo sodico
|
JP2010514702A
(ja)
|
2006-12-22 |
2010-05-06 |
アイロンウッド ファーマシューティカルズ,インコーポレーテッド |
食道障害の治療方法および治療用組成物
|
KR20090121388A
(ko)
*
|
2007-03-15 |
2009-11-25 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
신규 전구약물
|
WO2008146297A2
(fr)
*
|
2007-05-25 |
2008-12-04 |
Hetero Drugs Limited |
Procédé amélioré de preparation de rabéprazole sodique amorphe
|
WO2008155780A2
(fr)
*
|
2007-06-21 |
2008-12-24 |
Matrix Laboratories Ltd |
Procédé perfectionné pour la préparation de rabéprazole pur
|
WO2009010937A1
(fr)
*
|
2007-07-17 |
2009-01-22 |
Ranbaxy Laboratories Limited |
Procédé de préparation de pantoprazole sodique.
|
CN101497603B
(zh)
*
|
2008-01-30 |
2012-11-07 |
山东轩竹医药科技有限公司 |
含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
|
CN101497604B
(zh)
*
|
2008-01-30 |
2012-09-26 |
山东轩竹医药科技有限公司 |
含有被烷氧乙酰胺基氧基取代的吡啶的苯并咪唑衍生物
|
SI22806A
(sl)
*
|
2008-06-23 |
2009-12-31 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Nove kristalinične oblike natrijevega rabeprazola
|
US20120041030A1
(en)
|
2009-04-09 |
2012-02-16 |
Masaichi Yamamoto |
Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
|
WO2010134099A1
(fr)
|
2009-05-21 |
2010-11-25 |
Cadila Healthcare Limited |
Procédé de préparation dans un récipient unique d'oméprazole
|
WO2011004281A1
(fr)
|
2009-07-09 |
2011-01-13 |
Alembic Limited |
Procédé pour la préparation dune forme amorphe de rabéprazole sodium
|
CN102140099A
(zh)
|
2010-02-02 |
2011-08-03 |
山东轩竹医药科技有限公司 |
新的吡啶衍生物
|
WO2011121546A1
(fr)
*
|
2010-03-31 |
2011-10-06 |
Ranbaxy Laboratories Limited |
Sels de dexlansoprazole et leur élaboration
|
CN102219777B
(zh)
*
|
2010-04-19 |
2013-06-05 |
江苏豪森药业股份有限公司 |
制备雷贝拉唑钠的方法
|
CN101805327B
(zh)
*
|
2010-04-29 |
2012-11-21 |
郝志艳 |
一种雷贝拉唑钠化合物及其制法
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
CN104114169A
(zh)
|
2011-12-16 |
2014-10-22 |
阿托佩斯治疗有限公司 |
用于治疗嗜酸细胞性食管炎的crth2拮抗剂和质子泵抑制剂的组合物
|
WO2013108068A1
(fr)
|
2012-01-21 |
2013-07-25 |
Jubilant Life Sciences Limited |
Procédé de préparation de 2-pyridinylméthylsulfinylbenzimidazoles, leurs analogues et énantiomères optiquement actifs
|
WO2014091450A1
(fr)
|
2012-12-12 |
2014-06-19 |
Ranbaxy Laboratories Limited |
Procédé pour la préparation de rabéprazole
|
CN105338958A
(zh)
|
2013-01-15 |
2016-02-17 |
铁木医药有限公司 |
胆汁酸螯合剂的胃内滞留缓释口服剂型
|
CN103073536B
(zh)
*
|
2013-01-17 |
2015-06-24 |
丽珠医药集团股份有限公司 |
一种艾普拉唑的制备方法
|
CN103709141A
(zh)
*
|
2013-10-14 |
2014-04-09 |
寿光富康制药有限公司 |
雷贝拉唑钠的晶型及无定形形式
|
CN104119315B
(zh)
*
|
2014-05-21 |
2016-03-02 |
丽珠医药集团股份有限公司 |
一种雷贝拉唑钠的制备方法
|
RU2554735C1
(ru)
*
|
2014-08-20 |
2015-06-27 |
Открытое Акционерное Общество "Татхимфармпрепараты" |
Фармацевтическая композиция, содержащая рабепразол натрия, и способ ее получения
|
WO2016126625A1
(fr)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Méthodes de traitement de troubles gastro-intestinaux supérieurs de gerd réfractaire à ppi
|
EP3288556A4
(fr)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Compositions à désintégration par voie orale
|
US10736855B2
(en)
|
2016-02-25 |
2020-08-11 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
CN106083705A
(zh)
*
|
2016-06-14 |
2016-11-09 |
上药康丽(常州)药业有限公司 |
2‑羟甲基‑4‑(甲氧基丙氧基)‑3‑甲基吡啶盐酸盐的制备方法
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
CN106349220A
(zh)
*
|
2016-08-25 |
2017-01-25 |
岳阳正昊化学科技有限公司 |
一种右旋雷贝拉唑钠的纯化方法
|
JP7044789B2
(ja)
|
2016-09-24 |
2022-03-30 |
ワシントン・ユニバーシティ |
Sarm1 nadアーゼ活性の阻害剤およびその使用
|
JP2022548785A
(ja)
|
2019-09-24 |
2022-11-21 |
プロラクタ バイオサイエンス,インコーポレイテッド |
炎症性疾患及び免疫疾患の治療のための組成物及び方法
|
WO2024075017A1
(fr)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition de calcification de valve aortique
|